Published in Vaccine on May 16, 2003
Correlates of protection induced by vaccination. Clin Vaccine Immunol (2010) 5.21
Design of a protective single-dose intranasal nanoparticle-based vaccine platform for respiratory infectious diseases. PLoS One (2011) 1.20
New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin. Clin Exp Immunol (2013) 1.16
Strategies for eliciting HIV-1 inhibitory antibodies. Curr Opin HIV AIDS (2010) 1.05
Comparison of diagnostic criteria for common variable immunodeficiency disorder. Front Immunol (2014) 0.95
Immune Responses to pneumococcal vaccines in children and adults: Rationale for age-specific vaccination. Aging Dis (2011) 0.93
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine when administered to healthy Japanese adults aged ≥50 years. An open-label trial. Hum Vaccin Immunother (2014) 0.83
A systems approach to designing next generation vaccines: combining α-galactose modified antigens with nanoparticle platforms. Sci Rep (2014) 0.82
Salivary antibodies induced by the seven-valent PncOMPC conjugate vaccine in the Finnish Otitis Media Vaccine Trial. BMC Infect Dis (2005) 0.80
Correlation of pneumococcal antibody concentration and avidity with patient clinical and immunologic characteristics. J Clin Immunol (2013) 0.79
Re-examination of immune response and estimation of anti-Vi IgG protective threshold against typhoid fever-based on the efficacy trial of Vi conjugate in young children. Vaccine (2014) 0.78
Serological criteria and carriage measurement for evaluation of new pneumococcal vaccines. Hum Vaccin Immunother (2015) 0.78
Post hoc analysis of a randomized double-blind trial of the correlation of functional and binding antibody responses elicited by 13-valent and 7-valent pneumococcal conjugate vaccines and association with nasopharyngeal colonization. Clin Vaccine Immunol (2014) 0.77
Serotype 6B from a pneumococcal polysaccharide vaccine induces cross-functional antibody responses in adults to serotypes 6A, 6C, and 6D. Medicine (Baltimore) (2016) 0.75
Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin Diagn Lab Immunol (2003) 3.27
Efficacy results of a trial of a herpes simplex vaccine. N Engl J Med (2012) 2.77
Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. Clin Infect Dis (2012) 2.55
Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines. Clin Vaccine Immunol (2006) 2.00
Correlate of immune protection against HSV-1 genital disease in vaccinated women. J Infect Dis (2013) 1.82
From the NIH: proceedings of a workshop on the importance of self-obtained vaginal specimens for detection of sexually transmitted infections. Sex Transm Dis (2008) 1.58
Effect of O acetylation of Neisseria meningitidis serogroup A capsular polysaccharide on development of functional immune responses. Infect Immun (2002) 1.49
Description and nomenclature of Neisseria meningitidis capsule locus. Emerg Infect Dis (2013) 1.47
Phylogenetic lineages of invasive and colonizing strains of serotype III group B Streptococci from neonates: a multicenter prospective study. J Clin Microbiol (2006) 1.41
Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen. J Infect Dis (2004) 1.36
High burden of invasive Streptococcus agalactiae disease in South African infants. Ann Trop Paediatr (2003) 1.34
Experimental Gonococcal Infection in Male Volunteers: Cumulative Experience with Neisseria gonorrhoeae Strains FA1090 and MS11mkC. Front Microbiol (2011) 1.26
Evaluation of pneumococcal polysaccharide immunoassays using a 22F adsorption step with serum samples from infants vaccinated with conjugate vaccines. Clin Vaccine Immunol (2009) 1.25
Preparation and characterization of an immunogenic meningococcal group A conjugate vaccine for use in Africa. Vaccine (2008) 1.14
Characterization of antibodies to capsular polysaccharide antigens of Haemophilus influenzae type b and Streptococcus pneumoniae in human immune globulin intravenous preparations. Clin Diagn Lab Immunol (2004) 1.11
Identification of the Pseudomonas aeruginosa 1244 pilin glycosylation site. Infect Immun (2002) 1.00
Vaccines for otitis media: proposals for overcoming obstacles to progress. Vaccine (2005) 0.94
Protective immunity of pneumococcal glycoconjugates. Crit Rev Microbiol (2003) 0.93
Development and evaluation of pneumococcal conjugate vaccines: clinical trials and control tests. Crit Rev Microbiol (2002) 0.90
Capsular serotype of Staphylococcus aureus in the era of community-acquired MRSA. FEMS Immunol Med Microbiol (2011) 0.87
Vaccine research for gonococcal infections: where are we? Sex Transm Infect (2013) 0.85
Effect of a booster dose of serogroup B meningococcal vaccine on antibody response to Neisseria meningitidis in mice vaccinated with different immunization schedules. FEMS Immunol Med Microbiol (2005) 0.80
Immune response to native NadA from Neisseria meningitidis and its expression in clinical isolates in Brazil. J Med Microbiol (2003) 0.79
Immunologic and genetic characterization of lipooligosaccharide variants in a Neisseria meningitidis serogroup C strain. FEMS Immunol Med Microbiol (2002) 0.78